# Cardinal Health

Type: Company (CAH)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/cardinal-health
Canonical HTML page: https://getbiobrief.com/entity/cardinal-health

## Recent coverage (2 stories)

### Colorado’s $12M Opioid Grant Signals Ongoing Settlement Costs for Pharma
2026-08-02 19:24:34 · Sentiment: Neutral · Impact: 5/10 · Sources: 1

Colorado’s distribution of $12 million to 27 groups from opioid settlement funds is the latest reminder of pharma’s enduring financial and reputational liabilities. The grants, part of a broader $700M+ state settlement, fuel prevention programs while underscoring that litigation costs continue to ripple through the industry.
Full story: https://getbiobrief.com/story/colorado-opioid-settlement-pharma-liability-costs

### Amgen’s $36.8B Pipeline vs NovoCure’s Tumor-Fighting Tech: Which Innovator Wins?
2026-06-28 04:07:18 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Amgen brings a massive $36.8B revenue base and a broad chronic disease pipeline, while NovoCure pushes the frontier with electric‑field cancer therapy. This analysis weighs drug development scale against device‑based oncology innovation for biotech investors.
Full story: https://getbiobrief.com/story/amgen-vs-novocure-biopharma-innovation-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.